Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 3/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.53 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.43 |
| ▸ | HTR3E | A5X5Y0 | 2/20 | 0.43 |
| ▸ | HTR3B | O95264 | 2/20 | 0.43 |
| ▸ | HTR3A | P46098 | 2/20 | 0.43 |
| ▸ | HTR3D | Q70Z44 | 2/20 | 0.43 |
| ▸ | HTR3C | Q8WXA8 | 2/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.43 |
| ▸ | HTR2C | P28335 | 13/20 | 0.42 |
| ▸ | HTR2B | P41595 | 12/20 | 0.42 |
| ▸ | HTR2A | P28223 | 8/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HTR1D | P28221 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28145406 | 0.98 | SLC6A2 (0.51) | SLC6A2SLC6A4SLC6A3ADRB1HTR3E | |
| SCHEMBL31638970 | 0.89 | SLC6A2 (0.42) | SLC6A2SLC6A4SLC6A3HTR3EHTR3B | |
| SCHEMBL30958500 | 0.84 | SLC6A2 (0.37) | SLC6A2SLC6A4SLC6A3HTR2CHTR2B | |
| SCHEMBL38661363 | 0.84 | ADRB2 (0.46) | SLC6A2SLC6A4SLC6A3HTR2CHTR2B | |
| SCHEMBL20141340 | 0.81 | SLC6A2 (0.50) | SLC6A2SLC6A4SLC6A3ADRB1HTR3E | |
| SCHEMBL21360371 | 0.81 | SLC6A2 (0.50) | SLC6A2SLC6A4SLC6A3ADRB1HTR3E | |
| SCHEMBL21360373 | 0.81 | SLC6A2 (0.50) | SLC6A2SLC6A4SLC6A3ADRB1HTR3E | |
| SCHEMBL29079676 | 0.78 | SIRT6 (0.52) | ADRB1ALDH1A1 | |
| SCHEMBL2454158 | 0.77 | SLC6A2 (0.57) | SLC6A2SLC6A4SLC6A3ADRB1HTR3E | |
| SCHEMBL4563401 | 0.77 | PLD1 (0.50) | ADRB1HTR2CHTR2BHTR2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2983473-A2 | PHARMACEUTICAL COMPOSITION COMPRISING AN AMPK ACTIVATOR AND A SEROTONERGIC AGENT AND METHODS OF USE THEREOF | ALS Mountain Llc (US) | 2016-02-17 | — | — | EP | claimed |
| US-20140350064-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AN AMPK ACTIVATOR AND A SEROTONERGIC AGENT AND METHODS OF USE THEREOF | ALS MOUNTAIN LLC | 2014-11-27 | — | — | US | claimed |
| WO-2014144130-A2 | PHARMACEUTICAL COMPOSITION COMPRISING AN AMPK ACTIVATOR AND A SEROTONERGIC AGENT AND METHODS OF USE THEREOF | ALS MOUNTAIN LLC (US) | 2014-09-18 | — | — | WO | claimed |
| US-20120183600-A1 | NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME AND OTHER CONDITIONS | CHEN CHIEN-HUNG (US) | 2012-07-19 | — | — | US | claimed |
| CN-1122035-C | Antiparasitic artemisinin derivatives (endoperoxides) | BAYER AG (DE) | 2003-09-24 | — | — | CN | claimed |
| CN-1317006-A | Antiparasitic artemisinin derivatives (endoperoxides) | BAYER AG (DE) | 2001-10-10 | — | — | CN | claimed |
| JP-2000506513-A | — | — | 2000-05-30 | — | — | JP | claimed |
| EP-0880532-A4 | NON-NUCLEOTIDE PHOSPHOROUS ESTER OLIGOMERS | PHARMAGENICS INC (US) | 1999-06-09 | — | — | EP | claimed |
| EP-0880532-A1 | NON-NUCLEOTIDE PHOSPHOROUS ESTER OLIGOMERS | PHARMAGENICS, INC. (US) | 1998-12-02 | — | — | EP | claimed |
| EP-0804443-A4 | NON-NUCLEOTIDE PHOSPHORUS ESTER OLIGOMERS | PHARMAGENICS INC (US) | 1998-04-29 | — | — | EP | claimed |
| EP-0804443-A1 | NON-NUCLEOTIDE PHOSPHORUS ESTER OLIGOMERS | PHARMAGENICS, INC. (US) | 1997-11-05 | — | — | EP | claimed |
| WO-1997028168-A1 | NON-NUCLEOTIDE PHOSPHOROUS ESTER OLIGOMERS | PHARMAGENICS, INC. (US) | 1997-08-07 | — | — | WO | claimed |
| WO-1996022297-A9 | NON-NUCLEOTIDE PHOSPHORUS ESTER OLIGOMERS | — | 1996-10-03 | — | — | WO | claimed |
| WO-1996022297-A1 | NON-NUCLEOTIDE PHOSPHORUS ESTER OLIGOMERS | PHARMAGENICS, INC. (US) | 1996-07-25 | — | — | WO | claimed |
| EP-4049017-B1 | APPARATUS AND METHOD FOR DETERMINATION OF BANNED SUBSTANCES | TALLINN UNIV OF TECHNOLOGY (EE) | 2025-03-26 | — | — | EP | disclosed |
| US-12111260-B2 | Apparatus and method for determination of banned substances | TALLINN UNIVERSITY OF TECHNOLOGY (EE) | 2024-10-08 | — | — | US | disclosed |
| CN-114085197-B | Synthesis method of 4- (3-trifluoromethyl phenyl) -1-piperazine-ethanol, flibanserin intermediate and flibanserin | 合肥创新医药技术有限公司 | 2024-03-29 | — | — | CN | disclosed |
| EP-0310268-A2 | Substituted cycloalkanols | AMERICAN HOME PRODUCTS CORPORATION (US) | 1989-04-05 | — | — | EP | disclosed |
| US-4042590-A | ANTICHOLESTEROL | CENTRE D'ETUDES POUR L'INDUSTRIE PHARMACEUTIQUE (FR) | 1977-08-16 | — | — | US | disclosed |
| US-3957789-A | HYPOCHOLESEROLEMIC AGENTS | CENTRE D'ETUDES POUR L'INDUSTRIE PHARMACEUTIQUE (FR) | 1976-05-18 | — | — | US | disclosed |